Rand Merchant Investments, through its fintech investment arm AlphaCode, got a 25.1% minority stake in health startup Guidepost. The amount of this transaction is not disclosed yet but Guidepost will use the money to expand its network of partners working to improve access to care for diabetic patients.

Based in South Africa and London, Guidepost is a platform that connects people with diabetes to a team of diabetes doctors, insurers and scientists who are conducting research on the subject. During its six years of activity, the startup claims to have contributed to reducing the risk of diabetes complications by 45% for more than 8000 patients in South Africa. According to Dominique Collett (pictured), senior investment executive at Rand Merchant Investments, Guidepost will have the opportunity to extend its diagnostic and treatment platform to other chronic diseases and conditions on the continent through this funding.

Chamberline Moko